US 10772913
Administration of kynurenine depleting enzymes for tumor therapy
granted A61KA61K35/17A61K38/00
Quick answer
US patent 10772913 (Administration of kynurenine depleting enzymes for tumor therapy) held by The Board of Regents of the University of Texas System expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K35/17, A61K38/00, A61K38/46, A61P